Karampinis EmmanouilUniversity of Thessaly, Greece
Title: Psoriasis and COVID-19 era: Was a challenge effectively addressed?
Occasionally, vaccinations have been associated with side effects that involve inflammatory reactions that can interfere with the proper functioning of various organs, such as the skin. Ranging from cutaneous side effects such as erythema and urticaria to reactivation of infectious diseases such as herpes zoster, pre-existing skin disorders exacerbations and the appearance of different exanthems (morbilliform, petechial etc.), the reported dermatologic disturbances after COVID-19 vaccinations cover an extensive variety of dermatology diseases and have challenged the dermatology care and therapy. Many patients with chronic inflammatory dermatosis such as psoriasis usually ask about the safety of COVID-19 vaccination and if it would affect the course of their disease. Indeed, many case reports, case series and clinical studies, reporting psoriasis exacerbation following vaccination against COVID-19, were published during the pandemic. Also, many questions arise regarding the use of biologics and if the biologic therapy can affect the immunologic response of the vaccine. The speech would contain the main challenges in the approach of a psoriasis patient and what steps were followed to address the respective challenges.
Karampinis Emmanouil has completed his PhD at the age of 28 years on photocarcinogenesis and has 2 MScs in sections of clinical dermatology and dermoscopy respectively. His main work focuses on the skin manifestations of anti-COVID-19 vaccines and the concerns of dermatology patients during the pandemic era.